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transcription factor NF-kB is essential for the transcription of iNOS. The aim of this study 
was to assess wether NF-kB is activated in skeletal muscle of patients (pts) with CHF 
and linked to the expression of iNOS. 
Methods: Skeletal muscle biopsies were obtained from 7 CHF-pts (NYHA I1-~11; LVEF 19 
± 2%; VO2max 14.0 ± 1.3 ml/kg/min) and 7 healthy controls (HC) (LVEF 71 ± 2%; 
VO2max 28.3 ± 2.7 ml/kg/min). Nuclear proteins were isolated and the content of acti- 
vated NF-kB was analyzed by etectrophoretic mobility shift assay (EMSA). iNOS expres- 
sion in SM was determined by real time PCR and TNF-a concentration in the serum was 
measured by ELISA. 
Results: The expression of [NOS and the activation of NF-kB in the SM was significantly 
increased in CHF pts as compared to healthy controls (iNOS: 0.30 ± 0.04 vs. 0.09 ± 0.03 
relative RNA expression, p<0.01; NF-kB: 0.48 ± 0.10 vs. 0.12 ± 0.05 relative units). Addi- 
tionally serum TNF-a was significantly increased in CHF pts (CHF: 5.2 ± 0.6 vs. HC: 1.5 
± 0.2 pg/ml; p<O.001 ). Furthermore, a signifcant linear correlation was observed between 
NF-kB activation and iNOS expression (r--0.71, p<0.01) as well as between serum TNF- 
a and NF-kB activation ( r--O.8, p<0.01) 
Conclusion: The results of this study indicate for the first time that in skeletal muscle of 
patients with chronic heart failure the activation of transcription factor NF-kB is increased 
and may represent one important regulatory factor for the expression of )NOS. 
1156-143 Exposure  o f  Normal Adult Cediomyocytes to Active 
Caepaae-8 Triggers the Release of Cytochrome C From 
MItochondria Suppresses Mitochondrial Respiration 
Victor G. Sharov. Anastassia V. Tedor, Sidney Goldstein, Hani N. Sabbah, Henry Ford 
Health System, Detroit, Michigan. 
Background: We previously showed that mitochondrtal respiratory abnormalities exist in 
cardiomyocytes of human with end-stage heart failure as well as in cardiomyocytes of 
dogs with intracoronary microembolization-induced chronic heart failure. The factors that 
promote these abnormalities remain uncertain. One possible factor is activation of 
caspase-8 which, by activating Bid, promotes the release of cytochrome c from mlto- 
chondria that, in turn, results in mitochondrial dysfunction. In the present study, we tested 
the hypothesis that exposure of normal adult cardiomyocytes to active caspase-8, acti- 
vates bid, causes the release of cytochrome c from mitochondria nd adversely impacts 
mitochondrial respiration. 
Methods: Cardiomyocyte were enzimatically isolated from left ventdcular myocardium of 
5 normal dogs. Cardiomyocytes were saponin skinned, incubated under normoxic condi- 
tions (95%air/5%CO2), and exposed to active caspase-8 (100U/mr) for one hour. All- 
quotes of cardiomyocytes incubated with and without active caspase-8 were used to 
measure mitochondrial state 3 respiration with Clark electrode in the presence of 3 mM 
malate, 5 mM glutamate and 1 mM ADP. A second set of aliquotes of cardiomyocytes 
was centrifuged at 15,000 g and the supernatant used to measure the expression of 
cytosolic cytoohrome c and a third set was homogenized and the homogenate used to 
measure the expression of Bid by Western blotting. 
Results: Exposure of cardiomyocytes to active caspase-8 resulted in cleavage of Bid 
into 15 kDa fragments and markedly increased cytosolic cytochrome c (2.4 + 0.3 vs. 25.2 
_-t: 0.8, P<0.001) compared to unexposed cardiomyocytes. Exposure to caspase-8 also 
caused a significant decrease in mltochondrial state 3 respiration (39 -+ 4 vs. 64 -+ 13 ng 
atoms O2imin/mg protein, P<0.001 ). 
Conclusions: These results indicate that exposure of normal adult cardiomyocytes to 
active caspasa-8 triggers cleavage of Bid and the release of cytochrome c from mito- 
chondria with subsequent suppression of state respiration. This cascade of events offers 
an explanation for the observed abnormalities of mitochondrial respiration seen in heart 
failure. 
1156-144 Th io redox ln :  A New Marker of  Ox idat ive  St ress  in 
Patients With Chronic Heart Failure 
Andraas Jekell, Akter Hossain, Anders Rosdn, Ulf Dahlstrdm, LinkSping University, 
Link6ping, Sweden. 
Background: It is well known that pro-inflammatory cytokines are important prognostic 
markers in chronic heart failure (CHF) patients and it has been shown that tumor necro- 
sis factor-~x (TNFc¢) is elevated in plasma of CHF patients. Elevated levels of TNF~ are 
correlated with New York Heart Association (NYHA) functional class. Thioredoxin (Trx) is 
a multifunctional redox-protein, which regulate the intra- and extra cellular redox-environ- 
ment. One important function of Trx is the protection from oxidative stress caused by free 
radicals and pro-inflammatory cytokines. Trx is upregulatad both during chronic and 
acute oxidative conditions. However, it is not known whether Tr'x is elevated in systemic 
circulation in patients suffering from CHF. The aim of this study was to investigate possi- 
ble mechanisms behind CHF with special emphasis on the activation of cytokines and to 
see whether oxidative stress was playing a role. In order to assess these complex pro- 
cesses in CHF, we analyzed plasma levels of the redox-active proteins Trx and Trx- 
reductase (TrxR) as markers of oxidative stress and TNF(x and intedeukin 6 (IL6) as pro- 
inflammatory cytokines. 
Methoda: 27 male patients with CHF, NYHA class I1-111, and mean age 74 _+ 5 years 
(range 65-82) were compared to 30 healthy subjects of similar age-groups, mean age 75 
_+ 5 years (range 64 - 81). Plasma samples were collected in the morning after rest for 30 
min in supine position and analyzed in enzyme-linked immunosorbent assays (ELISA) for 
TNF, Trx, TrxR and IL6. 
Results: Patients with CHF showed a significant increase of Trx in plasma, mean 32 +__5 
(SEM) ng/ml, compared to healthy subjects (16 +4 ng/ml); p < 0.0001. Variations of 
plasma Trx were found in patients with CHF (range 9-101 ng/ml) as well as in healthy 
subjects (range 4-117 ng/ml). No significant differences in TNF~, IL6 nor TrxR concentra- 
tions were seen between the two groups. 
Conclusions: The most important finding in our pilot study is that Trx was significantly (p 
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< o.o0ol) elevated in patients with CHF compared to healthy subjects of similar age 
groups. This finding indicates that Trs may be a new sensitive marker of oxidative stress 
in CHF. 
1156-145 Anticytokine Therapy Alleviates Oxidative Stress and 
Attenuates Left Ventricular Remodeling in Experimental 
Heart  Fa i lure 
Gordon W. Moe, Andrea Konig, Marina Romanova, Peter Liu, St Michael's Hospital, 
Toronto, Ontario, Canada, University Health Network, Toronto. Ontario, Canada. 
Background: Increased expression of the prdmflammatory cytokine tumor necrosis fac- 
tor-alpha (TNF-(~) and increased oxidative stress have been observed in the failing head. 
TNF-c~ is known to induce oxidative stress /n vitro. Accordingly, this study tested the 
hypothesis that TNF-(x would also induce oxidative stress in vivo and contribute to LV 
dysfunction and remodeling in heart failure (HF). 
Methods: Dogs were randomly assigned to: (1) no pacing (controls, n=10), (2) chronic 
pacing for 4 weeks to severe HF (HF, n=10), and (3) pacing with concomitant reatment 
with etanercept, a chimeric TNF-~ soluble receptor, 0.5 mg/kg twice weekly SC (HF- 
etanercept, n=10). LV tissue level of aldehyde, an accurate marker of oxidative stess, 
was measured using gas chromatography/mass spectroscopy. LV function and remodel- 
ing was assessed by echocardlography. 
Results: LV tissue total aldehyde level increased markedly in HF, indicating severe oxi- 
dative stress. Selected unsaturated aldehydes such as 4-OH hexenal and malondialde- 
hyde were also increased. This was accompanied by reduced LV ejection fraction (LVEF) 
and increased LV volume (LVV), reflective of LV dysfunction and remodeling. Treatment 
with etanercept normalized LV aldehyde levels, reduced LVV, and partially restored 
LVEF. 
Conclusion: Our data provide supportive evidence that TNF.(x contributes to LV dys- 
function and remodeling in canine pacing-induced CHF, mediated in part by a local 
increase in oxidative stress. 
* p<O,OOl ve controls, ** p<O.O5 ve HF 
Controls HF HF-etanercept 
LVV (ml/kg) 3.4 + 0.5 5.2 + 0.4" 4.0 + 0.2** 
LVEF (%) 53 +_2 19 + 3* 26 + 2** 
Aldehydes (pmol/100 rag) 7048_+448 11760_+1410" 6991_+516"* 
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1157-153 A Simple Model to Predict Left Ventricular Systolic 
Dyefunction in a Multiethnic Community 
Gavin I. Gatasko, Roxy Senior, Avijit Lahid, Cardiology Research Department, Northwick 
Park Hospital, Harrow, United Kingdom. 
Background: Community-based programmes to screen for and treat left ventricular sys- 
tolic dysfunction (LVD) have recently been advocated. However, who best to invite for 
screening has not yet been fully elucidated. This study was undertaken to assess this fur- 
ther. 
Methods: 1403 subjects _> 45 years old were chosen at random from 7 geographical and 
socio-economically representative community practices to undergo a clinical assess- 
ment, symptom questionnaire, ECG, echocardiogram and fasting blood tests. A multi- 
variate model to predict the presence or absence of LVD was then constructed using 
both clinical and biochemical parameters. 
Results: 730 subjects (52%) attended. 515 (71%) were Caucasian and 168 (26%) South 
Asian. An ejection fraction (EF) was calculable by echocardiography using Simbson's 
apical biplane rule in 700 cases (96%). 38 subjects (5.4%) were found to have LVD. Of 
these 19 (50%) were entirely asymptomatic. Multivariate predictors of LVD included prior 
myocardial infarction, diabetes, a history of heavy alcohol usage, male sex, abnormal 
ECG and plasma N-terminal proBNP levels. No significant differences were seen with 
ethnicity. A multivariate model to predict LVD using these 6 parameters was constructed. 
It gave an area under the ROC curve of 0.95 for predicting significant LVD (EF <45%). A 
risk-score above 2.83 gave a sensitivity of 92% and specificity of 89% for predicting LVD, 
requiring only 14% of the population to undergo echocardiographic screening with a one- 
in-four pick up rate. 
Conclusion: Thus left ventdcular dysfunction is a common problem in multi-ethnic om- 
munities, has no racial difference in prevalence, is asymptomatic in half of cases, and 
has identifiable clinical and biochemical risk factors. Six simple clinical and biochemical 
markers can be used to successfully predict the presence or absence of LVD, potentially 
allowing a cost-effective targeted community-based echocardiographic screening pro- 
gramme for LVD. 
1157-154 Is Iso lated Diasto l ic  Heart  Fa i lure Tru ly  Stand Alone? 
Cheuk-Man Yu, Hong Lin, Hua Yang, Shun-Ling Kong, Steven Wai-Luen Lee, Chu-Pak 
Lau, The University of Hong Kong, Hong Kong, Hong Kong. 
Background: Definition of diastolic heart failure (DHF) relies on the use of sensitive tools 
to exclude the presence of systolic dysfunction. The use of ejection fraction of 50% as 
the cut-off point may not be adequate to address such task. We testify the hypothesis 
